nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.136	0.282	CbGbCtD
Argatroban—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.092	0.19	CbGbCtD
Argatroban—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0877	0.182	CbGbCtD
Argatroban—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0782	0.162	CbGbCtD
Argatroban—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0459	0.0949	CbGbCtD
Argatroban—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0433	0.0897	CbGbCtD
Argatroban—F2—leg—chronic obstructive pulmonary disease	0.0229	0.57	CbGeAlD
Argatroban—Retroperitoneal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.0163	0.0557	CcSEcCtD
Argatroban—Retroperitoneal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.0163	0.0557	CcSEcCtD
Argatroban—F2—Common Pathway—SERPINE2—chronic obstructive pulmonary disease	0.0133	0.0724	CbGpPWpGaD
Argatroban—F2—Intrinsic Pathway—SERPINE2—chronic obstructive pulmonary disease	0.0113	0.0616	CbGpPWpGaD
Argatroban—F2—Formation of Fibrin Clot (Clotting Cascade)—SERPINE2—chronic obstructive pulmonary disease	0.00765	0.0416	CbGpPWpGaD
Argatroban—F2—Platelet Aggregation (Plug Formation)—RAPGEF3—chronic obstructive pulmonary disease	0.00654	0.0355	CbGpPWpGaD
Argatroban—Gastrooesophageal reflux disease—Roflumilast—chronic obstructive pulmonary disease	0.0065	0.0222	CcSEcCtD
Argatroban—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00639	0.0347	CbGpPWpGaD
Argatroban—F2—respiratory system—chronic obstructive pulmonary disease	0.00569	0.142	CbGeAlD
Argatroban—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00565	0.0307	CbGpPWpGaD
Argatroban—Haematemesis—Aminophylline—chronic obstructive pulmonary disease	0.00563	0.0193	CcSEcCtD
Argatroban—F2—connective tissue—chronic obstructive pulmonary disease	0.00501	0.125	CbGeAlD
Argatroban—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00462	0.0251	CbGpPWpGaD
Argatroban—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00461	0.0158	CcSEcCtD
Argatroban—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.00449	0.0154	CcSEcCtD
Argatroban—Gastrooesophageal reflux disease—Aminophylline—chronic obstructive pulmonary disease	0.00433	0.0148	CcSEcCtD
Argatroban—Gastrooesophageal reflux disease—Tiotropium—chronic obstructive pulmonary disease	0.00408	0.014	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—TLR2—chronic obstructive pulmonary disease	0.00408	0.0222	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.00408	0.0222	CbGpPWpGaD
Argatroban—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00369	0.0126	CcSEcCtD
Argatroban—Myocardial ischaemia—Salbutamol—chronic obstructive pulmonary disease	0.0035	0.012	CcSEcCtD
Argatroban—F2—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00332	0.018	CbGpPWpGaD
Argatroban—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.0033	0.0113	CcSEcCtD
Argatroban—Vasodilation procedure—Salbutamol—chronic obstructive pulmonary disease	0.0032	0.0109	CcSEcCtD
Argatroban—Vasodilation—Salbutamol—chronic obstructive pulmonary disease	0.0032	0.0109	CcSEcCtD
Argatroban—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.00319	0.0109	CcSEcCtD
Argatroban—Gastrooesophageal reflux disease—Salbutamol—chronic obstructive pulmonary disease	0.00311	0.0106	CcSEcCtD
Argatroban—F2—lung—chronic obstructive pulmonary disease	0.00302	0.0752	CbGeAlD
Argatroban—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.003	0.0102	CcSEcCtD
Argatroban—F2—Regulation of IGF Activity by IGFBP—MMP1—chronic obstructive pulmonary disease	0.00296	0.0161	CbGpPWpGaD
Argatroban—F2—Blood Clotting Cascade—PLAU—chronic obstructive pulmonary disease	0.0028	0.0152	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.00274	0.0149	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.00264	0.0143	CbGpPWpGaD
Argatroban—F2—Complement and Coagulation Cascades—SERPINA1—chronic obstructive pulmonary disease	0.00259	0.0141	CbGpPWpGaD
Argatroban—Pulmonary oedema—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00856	CcSEcCtD
Argatroban—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00248	0.00848	CcSEcCtD
Argatroban—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00234	0.0127	CbGpPWpGaD
Argatroban—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.0023	0.0574	CbGeAlD
Argatroban—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.0078	CcSEcCtD
Argatroban—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.00228	0.0078	CcSEcCtD
Argatroban—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00227	0.0123	CbGpPWpGaD
Argatroban—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.00225	0.00771	CcSEcCtD
Argatroban—F2—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00223	0.0121	CbGpPWpGaD
Argatroban—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00218	0.0118	CbGpPWpGaD
Argatroban—F2—Blood Clotting Cascade—SERPINE1—chronic obstructive pulmonary disease	0.00217	0.0118	CbGpPWpGaD
Argatroban—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00736	CcSEcCtD
Argatroban—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00209	0.0114	CbGpPWpGaD
Argatroban—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00209	0.00713	CcSEcCtD
Argatroban—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00208	0.00711	CcSEcCtD
Argatroban—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00201	0.00686	CcSEcCtD
Argatroban—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00184	0.0063	CcSEcCtD
Argatroban—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.00622	CcSEcCtD
Argatroban—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00182	0.00622	CcSEcCtD
Argatroban—F2—Complement and Coagulation Cascades—PLAUR—chronic obstructive pulmonary disease	0.00181	0.00985	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.00618	CcSEcCtD
Argatroban—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.0018	0.00976	CbGpPWpGaD
Argatroban—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00179	0.00612	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00177	0.00961	CbGpPWpGaD
Argatroban—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00172	0.0059	CcSEcCtD
Argatroban—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00587	CcSEcCtD
Argatroban—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00585	CcSEcCtD
Argatroban—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00575	CcSEcCtD
Argatroban—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.00566	CcSEcCtD
Argatroban—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00561	CcSEcCtD
Argatroban—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00561	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—IL1B—chronic obstructive pulmonary disease	0.00164	0.00892	CbGpPWpGaD
Argatroban—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00561	CcSEcCtD
Argatroban—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00558	CcSEcCtD
Argatroban—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00558	CcSEcCtD
Argatroban—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.00554	CcSEcCtD
Argatroban—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00162	0.00554	CcSEcCtD
Argatroban—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00543	CcSEcCtD
Argatroban—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00543	CcSEcCtD
Argatroban—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00158	0.00859	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00157	0.00851	CbGpPWpGaD
Argatroban—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.00533	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—MMP9—chronic obstructive pulmonary disease	0.00155	0.00841	CbGpPWpGaD
Argatroban—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00154	0.00527	CcSEcCtD
Argatroban—F2—Post-translational protein modification—MUC5AC—chronic obstructive pulmonary disease	0.00153	0.00831	CbGpPWpGaD
Argatroban—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00523	CcSEcCtD
Argatroban—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00152	0.00827	CbGpPWpGaD
Argatroban—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00513	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.00144	0.00782	CbGpPWpGaD
Argatroban—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.00491	CcSEcCtD
Argatroban—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.0049	CcSEcCtD
Argatroban—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00485	CcSEcCtD
Argatroban—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00483	CcSEcCtD
Argatroban—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00481	CcSEcCtD
Argatroban—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00139	0.00757	CbGpPWpGaD
Argatroban—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.00474	CcSEcCtD
Argatroban—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00473	CcSEcCtD
Argatroban—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00137	0.00469	CcSEcCtD
Argatroban—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00466	CcSEcCtD
Argatroban—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00135	0.00462	CcSEcCtD
Argatroban—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00455	CcSEcCtD
Argatroban—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00451	CcSEcCtD
Argatroban—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.00451	CcSEcCtD
Argatroban—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.00448	CcSEcCtD
Argatroban—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00447	CcSEcCtD
Argatroban—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00446	CcSEcCtD
Argatroban—F2—Post-translational protein modification—MUC1—chronic obstructive pulmonary disease	0.0013	0.00707	CbGpPWpGaD
Argatroban—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00439	CcSEcCtD
Argatroban—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00438	CcSEcCtD
Argatroban—F2—Complement and Coagulation Cascades—PLAU—chronic obstructive pulmonary disease	0.00127	0.00691	CbGpPWpGaD
Argatroban—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.0043	CcSEcCtD
Argatroban—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00126	0.0043	CcSEcCtD
Argatroban—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.00425	CcSEcCtD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.00124	0.00675	CbGpPWpGaD
Argatroban—F2—Syndecan-4-mediated signaling events—MMP9—chronic obstructive pulmonary disease	0.00123	0.00668	CbGpPWpGaD
Argatroban—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.0042	CcSEcCtD
Argatroban—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.00419	CcSEcCtD
Argatroban—CYP3A5—lung—chronic obstructive pulmonary disease	0.00122	0.0305	CbGeAlD
Argatroban—F2—PAR1-mediated thrombin signaling events—NOS3—chronic obstructive pulmonary disease	0.00121	0.00657	CbGpPWpGaD
Argatroban—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00121	0.00657	CbGpPWpGaD
Argatroban—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00406	CcSEcCtD
Argatroban—F2—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00117	0.00637	CbGpPWpGaD
Argatroban—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00396	CcSEcCtD
Argatroban—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.0039	CcSEcCtD
Argatroban—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00389	CcSEcCtD
Argatroban—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00388	CcSEcCtD
Argatroban—Cough—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00388	CcSEcCtD
Argatroban—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00385	CcSEcCtD
Argatroban—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00381	CcSEcCtD
Argatroban—Cough—Montelukast—chronic obstructive pulmonary disease	0.00111	0.0038	CcSEcCtD
Argatroban—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00379	CcSEcCtD
Argatroban—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00379	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00111	0.00601	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—ALB—chronic obstructive pulmonary disease	0.0011	0.006	CbGpPWpGaD
Argatroban—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00377	CcSEcCtD
Argatroban—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00377	CcSEcCtD
Argatroban—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0011	0.00598	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00108	0.00586	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00368	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—NOS3—chronic obstructive pulmonary disease	0.00107	0.00583	CbGpPWpGaD
Argatroban—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00367	CcSEcCtD
Argatroban—Infection—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00361	CcSEcCtD
Argatroban—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00361	CcSEcCtD
Argatroban—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00105	0.00573	CbGpPWpGaD
Argatroban—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00358	CcSEcCtD
Argatroban—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00357	CcSEcCtD
Argatroban—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00356	CcSEcCtD
Argatroban—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00354	CcSEcCtD
Argatroban—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00354	CcSEcCtD
Argatroban—Infection—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00353	CcSEcCtD
Argatroban—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00352	CcSEcCtD
Argatroban—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00348	CcSEcCtD
Argatroban—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00101	0.0055	CbGpPWpGaD
Argatroban—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000996	0.00341	CcSEcCtD
Argatroban—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000993	0.00339	CcSEcCtD
Argatroban—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000993	0.00339	CcSEcCtD
Argatroban—F2—Complement and Coagulation Cascades—SERPINE1—chronic obstructive pulmonary disease	0.000984	0.00535	CbGpPWpGaD
Argatroban—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000983	0.00336	CcSEcCtD
Argatroban—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000979	0.00335	CcSEcCtD
Argatroban—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000973	0.00529	CbGpPWpGaD
Argatroban—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00097	0.00332	CcSEcCtD
Argatroban—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000955	0.00327	CcSEcCtD
Argatroban—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000947	0.00324	CcSEcCtD
Argatroban—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000947	0.00324	CcSEcCtD
Argatroban—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.0032	CcSEcCtD
Argatroban—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000935	0.0032	CcSEcCtD
Argatroban—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000935	0.0032	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000931	0.00506	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000925	0.00502	CbGpPWpGaD
Argatroban—F2—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000923	0.00502	CbGpPWpGaD
Argatroban—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000923	0.00316	CcSEcCtD
Argatroban—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000917	0.00314	CcSEcCtD
Argatroban—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.00314	CcSEcCtD
Argatroban—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000916	0.00313	CcSEcCtD
Argatroban—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000908	0.00311	CcSEcCtD
Argatroban—Pain—Formoterol—chronic obstructive pulmonary disease	0.000908	0.00311	CcSEcCtD
Argatroban—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000908	0.00311	CcSEcCtD
Argatroban—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000908	0.00311	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000904	0.00491	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.0009	0.00489	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000899	0.00489	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000898	0.00488	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000898	0.00307	CcSEcCtD
Argatroban—F2—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.000898	0.00488	CbGpPWpGaD
Argatroban—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000894	0.00306	CcSEcCtD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000892	0.00485	CbGpPWpGaD
Argatroban—Pain—Montelukast—chronic obstructive pulmonary disease	0.00089	0.00304	CcSEcCtD
Argatroban—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000889	0.00304	CcSEcCtD
Argatroban—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000887	0.00303	CcSEcCtD
Argatroban—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000884	0.00302	CcSEcCtD
Argatroban—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000883	0.00302	CcSEcCtD
Argatroban—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00088	0.00301	CcSEcCtD
Argatroban—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000879	0.00301	CcSEcCtD
Argatroban—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000879	0.00478	CbGpPWpGaD
Argatroban—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000875	0.00299	CcSEcCtD
Argatroban—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000875	0.00299	CcSEcCtD
Argatroban—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000874	0.00299	CcSEcCtD
Argatroban—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000872	0.00298	CcSEcCtD
Argatroban—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00087	0.00298	CcSEcCtD
Argatroban—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000869	0.00297	CcSEcCtD
Argatroban—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000869	0.00297	CcSEcCtD
Argatroban—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.00296	CcSEcCtD
Argatroban—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000858	0.00293	CcSEcCtD
Argatroban—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000858	0.00293	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—MMP1—chronic obstructive pulmonary disease	0.000857	0.00465	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000851	0.00291	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000851	0.00291	CcSEcCtD
Argatroban—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000844	0.00459	CbGpPWpGaD
Argatroban—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00084	0.00287	CcSEcCtD
Argatroban—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00084	0.00287	CcSEcCtD
Argatroban—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00084	0.00287	CcSEcCtD
Argatroban—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00084	0.00287	CcSEcCtD
Argatroban—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000837	0.00286	CcSEcCtD
Argatroban—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00083	0.00284	CcSEcCtD
Argatroban—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000829	0.00283	CcSEcCtD
Argatroban—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000829	0.00283	CcSEcCtD
Argatroban—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000827	0.00283	CcSEcCtD
Argatroban—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000825	0.00282	CcSEcCtD
Argatroban—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000824	0.00282	CcSEcCtD
Argatroban—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000823	0.00281	CcSEcCtD
Argatroban—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000823	0.00281	CcSEcCtD
Argatroban—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00082	0.0028	CcSEcCtD
Argatroban—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000814	0.00278	CcSEcCtD
Argatroban—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00081	0.00277	CcSEcCtD
Argatroban—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000809	0.00277	CcSEcCtD
Argatroban—F2—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000807	0.00438	CbGpPWpGaD
Argatroban—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0008	0.00435	CbGpPWpGaD
Argatroban—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000793	0.00271	CcSEcCtD
Argatroban—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000793	0.00271	CcSEcCtD
Argatroban—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000783	0.00268	CcSEcCtD
Argatroban—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000783	0.00268	CcSEcCtD
Argatroban—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000782	0.00267	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00078	0.00424	CbGpPWpGaD
Argatroban—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000767	0.00262	CcSEcCtD
Argatroban—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000739	0.00253	CcSEcCtD
Argatroban—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000735	0.004	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000733	0.00398	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000731	0.00397	CbGpPWpGaD
Argatroban—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.00248	CcSEcCtD
Argatroban—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000727	0.00248	CcSEcCtD
Argatroban—F2—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000726	0.00395	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000724	0.00393	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000715	0.00388	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000713	0.00388	CbGpPWpGaD
Argatroban—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000712	0.00243	CcSEcCtD
Argatroban—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000707	0.00384	CbGpPWpGaD
Argatroban—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000702	0.0024	CcSEcCtD
Argatroban—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000702	0.0024	CcSEcCtD
Argatroban—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000688	0.00235	CcSEcCtD
Argatroban—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.00235	CcSEcCtD
Argatroban—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00231	CcSEcCtD
Argatroban—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00231	CcSEcCtD
Argatroban—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00067	0.00229	CcSEcCtD
Argatroban—Rash—Formoterol—chronic obstructive pulmonary disease	0.00067	0.00229	CcSEcCtD
Argatroban—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000669	0.00229	CcSEcCtD
Argatroban—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.00229	CcSEcCtD
Argatroban—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000665	0.00228	CcSEcCtD
Argatroban—Headache—Formoterol—chronic obstructive pulmonary disease	0.000665	0.00228	CcSEcCtD
Argatroban—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000663	0.00227	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—chronic obstructive pulmonary disease	0.000662	0.0036	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000662	0.0036	CbGpPWpGaD
Argatroban—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000662	0.00226	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000657	0.00357	CbGpPWpGaD
Argatroban—Rash—Montelukast—chronic obstructive pulmonary disease	0.000656	0.00224	CcSEcCtD
Argatroban—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000655	0.00224	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000652	0.00354	CbGpPWpGaD
Argatroban—Headache—Montelukast—chronic obstructive pulmonary disease	0.000652	0.00223	CcSEcCtD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000648	0.00352	CbGpPWpGaD
Argatroban—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000646	0.00221	CcSEcCtD
Argatroban—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000643	0.0022	CcSEcCtD
Argatroban—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00218	CcSEcCtD
Argatroban—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00216	CcSEcCtD
Argatroban—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00216	CcSEcCtD
Argatroban—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000631	0.00216	CcSEcCtD
Argatroban—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000631	0.00216	CcSEcCtD
Argatroban—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000628	0.00215	CcSEcCtD
Argatroban—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000618	0.00211	CcSEcCtD
Argatroban—F2—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000618	0.00335	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000613	0.00333	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000605	0.00329	CbGpPWpGaD
Argatroban—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000599	0.00205	CcSEcCtD
Argatroban—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.00204	CcSEcCtD
Argatroban—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000591	0.00202	CcSEcCtD
Argatroban—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000588	0.00201	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000581	0.00315	CbGpPWpGaD
Argatroban—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000561	0.00192	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000551	0.003	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000548	0.00298	CbGpPWpGaD
Argatroban—F2—Post-translational protein modification—PLAUR—chronic obstructive pulmonary disease	0.000539	0.00293	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000536	0.00291	CbGpPWpGaD
Argatroban—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00183	CcSEcCtD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000533	0.00289	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.00053	0.00288	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000526	0.00286	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00052	0.00282	CbGpPWpGaD
Argatroban—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000492	0.00168	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000479	0.0026	CbGpPWpGaD
Argatroban—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000474	0.00162	CcSEcCtD
Argatroban—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000468	0.00254	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000468	0.00254	CbGpPWpGaD
Argatroban—F2—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000463	0.00252	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000463	0.00252	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000454	0.00247	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000452	0.00245	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00043	0.00234	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000428	0.00233	CbGpPWpGaD
Argatroban—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000424	0.00145	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000421	0.00229	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00042	0.00228	CbGpPWpGaD
Argatroban—Infection—Prednisone—chronic obstructive pulmonary disease	0.000415	0.00142	CcSEcCtD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000415	0.00225	CbGpPWpGaD
Argatroban—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000408	0.00139	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000406	0.0022	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000402	0.00218	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000389	0.00212	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000387	0.0021	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000384	0.00209	CbGpPWpGaD
Argatroban—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00038	0.0013	CcSEcCtD
Argatroban—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000378	0.00205	CbGpPWpGaD
Argatroban—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000368	0.00126	CcSEcCtD
Argatroban—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.00124	CcSEcCtD
Argatroban—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.00124	CcSEcCtD
Argatroban—F2—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.00036	0.00196	CbGpPWpGaD
Argatroban—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00036	0.00123	CcSEcCtD
Argatroban—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000357	0.00122	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000355	0.00193	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000351	0.00191	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000346	0.00188	CbGpPWpGaD
Argatroban—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00118	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000342	0.00186	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000342	0.00117	CcSEcCtD
Argatroban—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000342	0.00117	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000342	0.00186	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000341	0.00185	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.00034	0.00185	CbGpPWpGaD
Argatroban—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00033	0.00113	CcSEcCtD
Argatroban—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00033	0.00113	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000327	0.00178	CbGpPWpGaD
Argatroban—F2—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000325	0.00177	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000325	0.00176	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00032	0.00174	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000312	0.00169	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000309	0.00168	CbGpPWpGaD
Argatroban—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00105	CcSEcCtD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000305	0.00166	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000301	0.00164	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000298	0.00162	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000294	0.0016	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	0.00029	0.00158	CbGpPWpGaD
Argatroban—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000978	CcSEcCtD
Argatroban—F2—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000285	0.00155	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000283	0.00154	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00154	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00152	CbGpPWpGaD
Argatroban—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000945	CcSEcCtD
Argatroban—F2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000274	0.00149	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00027	0.00147	CbGpPWpGaD
Argatroban—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000909	CcSEcCtD
Argatroban—Rash—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000901	CcSEcCtD
Argatroban—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000263	0.0009	CcSEcCtD
Argatroban—Headache—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000895	CcSEcCtD
Argatroban—F2—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000256	0.00139	CbGpPWpGaD
Argatroban—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000849	CcSEcCtD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.00134	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000235	0.00128	CbGpPWpGaD
Argatroban—F2—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000232	0.00126	CbGpPWpGaD
Argatroban—F2—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000228	0.00124	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	0.000228	0.00124	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000219	0.00119	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000218	0.00118	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000217	0.00118	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000216	0.00117	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000215	0.00117	CbGpPWpGaD
Argatroban—F2—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000209	0.00114	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000207	0.00113	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000195	0.00106	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000183	0.000993	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.000983	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00097	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000177	0.000964	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000177	0.000961	CbGpPWpGaD
Argatroban—F2—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000176	0.000958	CbGpPWpGaD
Argatroban—F2—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000176	0.000956	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000175	0.000949	CbGpPWpGaD
Argatroban—F2—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000168	0.000915	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000167	0.000908	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000167	0.000907	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000166	0.000904	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000159	0.000862	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000153	0.00083	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000151	0.00082	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000151	0.000819	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000149	0.000809	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	0.000147	0.000797	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000139	0.000754	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000139	0.000754	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000137	0.000743	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000136	0.000741	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.000714	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.000705	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000122	0.000664	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000121	0.000659	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000117	0.000638	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000114	0.000617	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000111	0.000605	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000106	0.000575	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000105	0.00057	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.44e-05	0.000513	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.37e-05	0.000509	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—chronic obstructive pulmonary disease	9.17e-05	0.000498	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.57e-05	0.000466	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.52e-05	0.000463	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.2e-05	0.000445	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.01e-05	0.000435	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	7.92e-05	0.00043	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.62e-05	0.000414	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	7.23e-05	0.000393	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.01e-05	0.000381	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.82e-05	0.00037	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.66e-05	0.000362	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.34e-05	0.000344	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.27e-05	0.00034	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.98e-05	0.000325	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.71e-05	0.00031	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.55e-05	0.000302	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.48e-05	0.000298	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.1e-05	0.000277	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.06e-05	0.000275	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.84e-05	0.000263	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.81e-05	0.000262	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.58e-05	0.000249	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.11e-05	0.000223	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.77e-05	0.000205	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.72e-05	0.000202	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.7e-05	0.000201	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.68e-05	0.0002	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.36e-05	0.000183	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	3.29e-05	0.000179	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	3.15e-05	0.000171	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.11e-05	0.000169	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.1e-05	0.000168	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.84e-05	0.000155	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.58e-05	0.00014	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.55e-05	0.000138	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.37e-05	0.000129	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.000122	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.53e-05	8.31e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.46e-05	7.94e-05	CbGpPWpGaD
